Calydon

Calydon, Inc. is a gene therapy company focused on the development and commercialization of cancer vaccines and gene therapies to treat life-threatening major diseases. The company uses its Attenuated Replication Competent Adenovirus (ARCA™) technology to create oncolytic viruses that only kill cancer cells. Multiple products based on ARCA™ have shown encouraging results in clinical and preclinical studies for various cancers, including prostate cancer, colon cancer, bladder cancer, and liver cancer.